SCHEMBL8487704

SCHEMBL8487704

CC(=O)Nc1ccc(-c2cc(-c3ccc(C)cc3)cc(-c3ccccc3)n2)cc1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.70
KMT2A Q03164 7/20 0.70
KDM4E B2RXH2 7/20 0.70
MEN1 O00255 6/20 0.70
HPGD P15428 5/20 0.70
MAPT P10636 3/20 0.70
RXFP1 Q9HBX9 2/20 0.70
NPSR1 Q6W5P4 1/20 0.70
CYP2C19 P33261 1/20 0.70
ADORA3 P0DMS8 5/20 0.66
ADORA1 P30542 2/20 0.63
ADORA2B P29275 1/20 0.63
PDE10A Q9Y233 2/20 0.57
CYP3A4 P08684 1/20 0.56
TDP1 Q9NUW8 1/20 0.56
NPC1 O15118 2/20 0.54
RAB9A P51151 2/20 0.54
SMN1; SMN2 Q16637 2/20 0.54
POLB P06746 1/20 0.54
NFKB1 P19838 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8485197 0.94 KMT2A (0.78) ALDH1A1KMT2AKDM4EMEN1HPGD
SCHEMBL8484513 0.91 ADORA3 (0.61) ALDH1A1KMT2AKDM4EMEN1HPGD
SCHEMBL27416186 0.84 KMT2A (0.64) ALDH1A1KMT2AKDM4EMEN1HPGD
SCHEMBL2754553 0.82 KMT2A (1.00) ALDH1A1KMT2AKDM4EMEN1HPGD
SCHEMBL8769970 0.82 ALDH1A1 (0.54) ALDH1A1KMT2AKDM4EMEN1HPGD
SCHEMBL8619064 0.82 MEN1 (0.64) ALDH1A1KMT2AKDM4EMEN1HPGD
SCHEMBL16376447 0.82 MEN1 (0.77) ALDH1A1KMT2AKDM4EMEN1HPGD
SCHEMBL20220277 0.82 MEN1 (0.77) ALDH1A1KMT2AKDM4EMEN1HPGD
SCHEMBL20413823 0.82 MEN1 (0.77) ALDH1A1KMT2AKDM4EMEN1HPGD
SCHEMBL12655454 0.82 MEN1 (0.77) ALDH1A1KMT2AKDM4EMEN1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5922743-A USEFUL FOR AMELIORATION OF NERVE DISORDERS DUE TO NEURONAL DEGENERATION, SUCH AS INDUCED BY DRUGS OR ALCOHOL, INFLAMMATORY DISORDERS, DIABETES, ALZHEIMER'S DISEASE, PARKINSON'S DISEASE, HUNTINGTON'S CHOREA, AND OTHERS TAISHO PHARMACEUTICAL CO., LTD. (JP) 1999-07-13 US disclosed
EP-0795545-A1 PYRIDINE DERIVATIVES TAISHO PHARMACEUTICAL CO. LTD (JP) 1997-09-17 EP disclosed